Clozapine N-oxide | B1925

Clozapine N-oxide is a metabolite of clozapine that activates human muscarinic designer receptors (DREADDs) in vitro.

Clozapine N-oxide is a metabolite of clozapine that activates human muscarinic designer receptors (DREADDs) in vitro.

B1925 | Clozapine N-oxide DataSheet

Alternate Name/Synonyms: 8-Chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine

Appearance: White solid

Formulation: N/A

CAS Number: 34233-69-7

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₈H₁₉ClN₄O

Molecular Weight: 342.82

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO (>5 mg/ml)

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A DREADD agonist

MDL Number: MFCD00210190

PubChem CID: 2819

SMILES: C[N+]1(CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl)[O-]

InChi: InChI=1S/C18H19ClN4O/c1-23(24)10-8-22(9-11-23)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,21H,8-11H2,1H3

InChi Key: WYRDWWAASBTJLM-UHFFFAOYSA-N